Bringing meaningful 3D printing applications to hospitals – Presented by Pieter Slagmolen, Materialise

Pieter Slagmolen

Bringing meaningful 3D printing applications to hospitals – Presented by Pieter Slagmolen, Materialise at the 3D Medical Conference 2018,  which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.

3D printing is becoming an increasingly important part of personalized medicine workflows through the delivery of tailored medical devices, for visualization of anatomy, as custom surgical tools or for patient-specific implants. An increasing number of hospitals are internalizing 3D printing as a service to complement clinical and research programs. With a proper alignment of clinical goals and applications with appropriate technology choices and processes, sustainable growth of a hospital-driven 3D printing program can be achieved. This talk will discuss some of the opportunities and challenges that are crucial in allowing clinicians and patients to maximally benefit from the meaningful applications that 3D printing can enable. Continue reading “Bringing meaningful 3D printing applications to hospitals – Presented by Pieter Slagmolen, Materialise”

Materialise announce pre-market phase of development for mitral valve planning

Materialise

Materialise announce pre-market phase of development for mitral valve planning

Mitral regurgitation affects more than 4 million Americans – nearly one in 10 people aged 75 or older. Currently the primary option for the disease is open-heart surgery, which holds extremely high risks for patients in this age group and can prevent treatment in many cases. Non-invasive methods are entering the market to address this need and physicians are recognizing the importance of pre-surgical planning for this complex disease. Entering their pre-market phase of development, Materialise is working with select U.S. and EU hospital partners to validate the importance of accurate 3D modeling to help physicians plan complex transcatheter mitral valve replacement & repair (TMVR/r) procedures.

The pre-market phase will assess the importance of accurate 3D modeling for robust, repeatable patient planning. Materialise has partnered with Henry Ford Health Systems to bring Henry Ford’s validated, patented, mitral planning workflow, developed in Materialise’s Mimics Innovation Suite to a broader TMVR Market. Continue reading “Materialise announce pre-market phase of development for mitral valve planning”

The transformative power of co-creation observed through the lens of Additive Manufacturing – Presented by Kristel Van den Bergh, Materialise

Kristel Van den Bergh

The transformative power of co-creation observed through the lens of Additive Manufacturing – Presented by Kristel Van den Bergh, Materialise, at the 3D Medtech Printing Conference, February 01, 2017, at MECC Maastricht, The Netherlands.

Additive manufacturing presents many exciting opportunities for the Medtech and wearables space, from rapid prototyping to final certified production. However, this raises questions with regards to product development:

  • How can we make the most of 3DP opportunities to create the greatest value?
  • How to ensure companies build innovations that are relevant for its customers and welcomed by the stakeholders in the ecosystem?
  • How do these innovations transform the way professionals interact with their customers?
  • How will supply chains for digitally manufactured applications change?

Through practical case studies from the medical and wearables industries, we will demonstrate the value of open innovation thinking where meaningful applications emerge through a guided co-collaborative process. Continue reading “The transformative power of co-creation observed through the lens of Additive Manufacturing – Presented by Kristel Van den Bergh, Materialise”

The Hibbot: Giving Children with Cerebral Palsy the Chance to Walk (Video)

The Hibbot: Giving Children with Cerebral Palsy the Chance to Walk .Meet Yano De Laet, a young boy who suffers from Cerebral Palsy. Cerebral Palsy (CP) is a permanent movement disorder caused by a lesion in the developmental brain which causes muscle weakness, abnormal tone, movement disorders and balance problems. The brain damage often occurs before or during the birth of the child, and there is no cure for the condition. Yano regularly undergoes consultations at the Cerebral Palsy Reference Center at Pellenberg, UZ Leuven in Belgium, and after hearing about the Hibbot, his doctor thought he would be an ideal candidate for the project. Continue reading “The Hibbot: Giving Children with Cerebral Palsy the Chance to Walk (Video)”